FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1932023311> ?p ?o ?g. }

• W1932023311 endingPage "7" @default.
• W1932023311 startingPage "2153" @default.
• W1932023311 abstract "Kaposi's sarcoma (KS) is the most frequent neoplasm occurring in patients with HIV-related AIDS and very often exhibits multifocal distribution so that a systemic approach is needed. KS is considered a radiosensitive tumor and (RT) has always played an important role in the therapeutic strategy of its various forms. RT is a valuable means of pain relief, bleeding control and edema palliation, but it is also an effective treatment modality for local control of skin and mucosal lesions in KS. The purpose of the present article is to report the results obtained by the Radiotherapy Unit of S. Camillo-Forlanini Hospital in Rome in the management of 38 AIDS-associated KS lesions and to assess the efficacy of RT in the treatment and local control of KS.Eighteen patients histologically-diagnosed with HIV-related KS underwent RT in the period between January 2002 and January 2012 at the Radiotherapy Unit of S. Camillo-Forlanini Hospital in Rome. In all cases, the lesions caused pain or discomfort and a thorough careful clinical evaluation had indicated a radiation treatment. A total of 38 lesions were treated with radiotherapy. Fifteen patients received systemic chemotherapy. Eight patients with multiple cutaneous lesions on their legs and arms were treated with a radiation schedule prescribing extended cutaneous irradiation using 6-18 MeV electron beam energy, 200 cGy per fraction and a total dose between 24-30 Gy, according to the depth of lesions. One of these patients had also a cutaneous lesion on an eyelid that was treated with a radiation schedule using 6 MeV electron beam energy and bolus of 1 cm, 200 cGy per fraction and a total dose of 30 Gy. Seven patients with single cutaneous lesions on the legs and arms were treated using a photon regimen of 6 Mv energy, 200 cGy per fraction and a total dose between 20 and 36 Gy. Two patients had oral mucosa lesions and they were treated with a radiation schedule prescribing irradiation using 6 Mev photon regimen and personal mask, 200 cGy per fraction and a total dose of 24 and 30 Gy, respectively. A patient with a single bone lesion on the spinal column was treated with irradiation using 6 Mev photon regimen, 300 cGy per fraction and a total dose of 30 Gy.At the time of reporting, 14 patients were alive and four patients had died. One patient died due to complications from HIV infection. The follow-up from the end of the treatment ranged from four to 124 months (mean=51.17 months). The overall survival for the group was 88.8% at one year. The mean overall survival was 57.4 months. A complete response was achieved for 31 lesions (83.8 %); a partial response with a tumor regression was observed for six lesions (16.2 %). No relapses were observed during the period of follow-up, but we observed new lesions in one patient. According to the Radiation Therapy Oncology Group scale we observed erythematic and dry desquamation (grade 1) in eight sites (21%); in only one patient (2.6%) did stomatitis occur (grade 1). Good cosmetic results were described for 25 (65.7%) out of 31 lesions. Effective palliative action was obtained for all lesions except for two (5.2%) located in a vertebra and hard palate.RT will be a mainstay of cure for this group of patients especially when of young age and the will to preserve the cosmetic appearance is a primary need." @default.
• W1932023311 created "2016-06-24" @default.
• W1932023311 creator A5001527801 @default.
• W1932023311 creator A5015463164 @default.
• W1932023311 creator A5021169770 @default.
• W1932023311 creator A5032116207 @default.
• W1932023311 creator A5058494438 @default.
• W1932023311 creator A5063994971 @default.
• W1932023311 creator A5091281560 @default.
• W1932023311 date "2013-05-01" @default.
• W1932023311 modified "2023-09-23" @default.
• W1932023311 title "Radiation therapy in the treatment of HIV-related Kaposi's sarcoma." @default.
• W1932023311 cites W1791637602 @default.
• W1932023311 cites W1946681513 @default.
• W1932023311 cites W1980789591 @default.
• W1932023311 cites W2012992638 @default.
• W1932023311 cites W2022481827 @default.
• W1932023311 cites W2023548048 @default.
• W1932023311 cites W2032438721 @default.
• W1932023311 cites W2037976026 @default.
• W1932023311 cites W2054801876 @default.
• W1932023311 cites W2066250170 @default.
• W1932023311 cites W2087778464 @default.
• W1932023311 cites W2092081197 @default.
• W1932023311 cites W2097681908 @default.
• W1932023311 cites W2097988986 @default.
• W1932023311 cites W2106016270 @default.
• W1932023311 cites W2125726664 @default.
• W1932023311 cites W2414337315 @default.
• W1932023311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23645769" @default.
• W1932023311 hasPublicationYear "2013" @default.
• W1932023311 type Work @default.
• W1932023311 sameAs 1932023311 @default.
• W1932023311 citedByCount "14" @default.
• W1932023311 countsByYear W19320233112014 @default.
• W1932023311 countsByYear W19320233112015 @default.
• W1932023311 countsByYear W19320233112017 @default.
• W1932023311 countsByYear W19320233112018 @default.
• W1932023311 countsByYear W19320233112019 @default.
• W1932023311 countsByYear W19320233112020 @default.
• W1932023311 countsByYear W19320233112021 @default.
• W1932023311 countsByYear W19320233112022 @default.
• W1932023311 countsByYear W19320233112023 @default.
• W1932023311 crossrefType "journal-article" @default.
• W1932023311 hasAuthorship W1932023311A5001527801 @default.
• W1932023311 hasAuthorship W1932023311A5015463164 @default.
• W1932023311 hasAuthorship W1932023311A5021169770 @default.
• W1932023311 hasAuthorship W1932023311A5032116207 @default.
• W1932023311 hasAuthorship W1932023311A5058494438 @default.
• W1932023311 hasAuthorship W1932023311A5063994971 @default.
• W1932023311 hasAuthorship W1932023311A5091281560 @default.
• W1932023311 hasConcept C126838900 @default.
• W1932023311 hasConcept C141071460 @default.
• W1932023311 hasConcept C142724271 @default.
• W1932023311 hasConcept C2776694085 @default.
• W1932023311 hasConcept C2778256501 @default.
• W1932023311 hasConcept C2779236070 @default.
• W1932023311 hasConcept C2781156865 @default.
• W1932023311 hasConcept C3018958071 @default.
• W1932023311 hasConcept C509974204 @default.
• W1932023311 hasConcept C71924100 @default.
• W1932023311 hasConceptScore W1932023311C126838900 @default.
• W1932023311 hasConceptScore W1932023311C141071460 @default.
• W1932023311 hasConceptScore W1932023311C142724271 @default.
• W1932023311 hasConceptScore W1932023311C2776694085 @default.
• W1932023311 hasConceptScore W1932023311C2778256501 @default.
• W1932023311 hasConceptScore W1932023311C2779236070 @default.
• W1932023311 hasConceptScore W1932023311C2781156865 @default.
• W1932023311 hasConceptScore W1932023311C3018958071 @default.
• W1932023311 hasConceptScore W1932023311C509974204 @default.
• W1932023311 hasConceptScore W1932023311C71924100 @default.
• W1932023311 hasIssue "5" @default.
• W1932023311 hasLocation W19320233111 @default.
• W1932023311 hasOpenAccess W1932023311 @default.
• W1932023311 hasPrimaryLocation W19320233111 @default.
• W1932023311 hasRelatedWork W2019694656 @default.
• W1932023311 hasRelatedWork W2028800748 @default.
• W1932023311 hasRelatedWork W2051964401 @default.
• W1932023311 hasRelatedWork W2113906005 @default.
• W1932023311 hasRelatedWork W2156156856 @default.
• W1932023311 hasRelatedWork W2230522317 @default.
• W1932023311 hasRelatedWork W2361185275 @default.
• W1932023311 hasRelatedWork W2381389641 @default.
• W1932023311 hasRelatedWork W2397594479 @default.
• W1932023311 hasRelatedWork W2420845136 @default.
• W1932023311 hasVolume "33" @default.
• W1932023311 isParatext "false" @default.
• W1932023311 isRetracted "false" @default.
• W1932023311 magId "1932023311" @default.
• W1932023311 workType "article" @default.